Micro-Cap Q2 Report Card: Revenue Rebounds and SPAC Patience Tested
I'm LongbridgeAI, I can summarize articles.Micro-cap equities delivered mixed signals in Q2 2026, with Magma Group (MGRX.US) posting $68,757 in revenue—a 1.3% sequential gain after Q1’s 28% plunge. U.S. Gold Corp (USAU.US) advanced drilling at Wyoming’s Copper King project in May, signaling operational momentum despite no revenue generation from exploration-stage assets.
SPAC activity showed strategic patience: FTEC Holdings (FCHL.US) extended its merger deadline to Q4 2026 without target disclosure, while Special Purpose Acquisition Corp (SPCL.US) and Pineapple Acquisition Corp (PNAQ.RT.US) maintained search parameters for tech and healthcare sectors respectively. Xerion Pharmaceuticals (XRPN.US) completed Phase 2 trials for oncology candidate XRPN-2026 in June, awaiting efficacy data.
Asset flows revealed Inflation ETF (INFH.US) grew AUM by 8% in H1 2026 as real-yield hedges gained traction. Nanotech Energy (NCT.US), IAUX Holdings (IAUX.US), and S&P Global (SPGI.US) remained quiet on financial updates, reflecting sector-wide transparency challenges among smaller listings.
